VariZIG™ is a highly purified and specialized antibody product that contains antibodies specific for the Varicella zoster virus, which causes the viral infection known as "chickenpox". VariZIG™ is approved in Canada.
Availability in the United States
VariZIG™ is available in the U.S. under an investigational new drug application (IND) Expanded Access Protocol. An Expanded Access Protocol enables healthcare professionals to access and administer the VariZIG™, to patients who meet the protocol's enrolment criteria. Additional information regarding the Expanded Access Protocol is available at
http://www.fda.gov/BiologicsBloodVaccines/
SafetyAvailability/ucm176029.htmThis link will send you outside of the Cangene website
Canada
General Enquiries:
Tel: 1-877-Cangene (1-877-226-4363)
Email: sales@cangene.com
Product Enquiries:
Tel: (416) 675-8286
Email: salesmanager@cangene.com
United States
Distributor: FFF Enterprises
Tel: 1-800-843-7477
FFF EnterprisesThis link will send you outside of the Cangene website
International
Product Enquiries:
Tel: (204) 275-4374
Email: directorofsales@cangene.com
More Information About VariZIG™: [Varicella Zoster Immune Globulin (Human)]
The following information is available in Adobe Acrobat Canadian Product Monographs:English
French